AEGiS-ST: New ways needed to fight TB Sunday Times (Johannesburg)Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to Sunday Times (Johannesburg) main menu
DonateNow
Print this article

New ways needed to fight TB

Sunday Times (Johannesburg) - November 13, 2007
Anton Ferreira


SA's programme lags those of some of the less well-off countries.

THE surge in the number of infections caused by the deadly, mutant form of tuberculosis is the legacy of mistakes in fighting the disease over the decades.

That's the verdict of Nils Billo, head of the International Union against Tuberculosis and Lung Disease, who said yesterday that South Africa's TB programme lagged those of some of the less well-off countries in Africa.

He was speaking in Cape Town at the end of a five-day conference on lung diseases at which it was revealed that South Africa had 6716 cases of multi-drug resistant TB and 481 cases of extensively drug resistant TB last year. There are no antibiotics to fight extensively drug resistant TB.

Billo said: "If you have a lot of multi- and extensively drug resistant TB, there's something wrong with the system. Probably, in the past 20 years, mistakes have been made, as in many countries."

Another lung disease expert, Don Enarson, from Canada, said: "If you go to any hospital in South Africa y ou have to pass a long line of patients who sit there for hours on end - and they're coughing. If you mix people with HIV with TB patients, you have a problem."

Billo criticised the developed world for not doing enough to develop new ways of fighting TB .

He said: "The pharmaceutical industry does not see a big profit in developing a TB drug. Much more money should be spent on developing new tools."


071113
ST071104


Copyright © 2007 - The Sunday Times. Reproduction of this article (other than one copy for personal reference) must be cleared through the Sunday Times Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .